These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. McAllister SD; Rizvi G; Anavi-Goffer S; Hurst DP; Barnett-Norris J; Lynch DL; Reggio PH; Abood ME J Med Chem; 2003 Nov; 46(24):5139-52. PubMed ID: 14613317 [TBL] [Abstract][Full Text] [Related]
9. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling. Newman-Tancredi A; Cussac D; Marini L; Millan MJ Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435 [TBL] [Abstract][Full Text] [Related]
10. Galphai1 and Galphai3 differentially interact with, and regulate, the G protein-activated K+ channel. Ivanina T; Varon D; Peleg S; Rishal I; Porozov Y; Dessauer CW; Keren-Raifman T; Dascal N J Biol Chem; 2004 Apr; 279(17):17260-8. PubMed ID: 14963032 [TBL] [Abstract][Full Text] [Related]
11. The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. Vásquez C; Lewis DL J Neurosci; 1999 Nov; 19(21):9271-80. PubMed ID: 10531431 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1. van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790 [TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084 [TBL] [Abstract][Full Text] [Related]
14. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255 [TBL] [Abstract][Full Text] [Related]
15. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor. Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation. Clark MJ; Furman CA; Gilson TD; Traynor JR J Pharmacol Exp Ther; 2006 May; 317(2):858-64. PubMed ID: 16436499 [TBL] [Abstract][Full Text] [Related]
18. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC. Araya KA; David Pessoa Mahana C; González LG Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the CB Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186 [TBL] [Abstract][Full Text] [Related]
20. Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor. Rhee MH; Nevo I; Bayewitch ML; Zagoory O; Vogel Z J Neurochem; 2000 Dec; 75(6):2485-91. PubMed ID: 11080201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]